Security record · archived quarter
AQST
Aquestive Therapeutics, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
16Tracked holders
0Δ holders
21.57MShares held
$120.55MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +3.2% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | +3 | 39.01M | $162.27M | +5 | −2 |
| Q1 2026 | 71 | -4 | 39.34M | $163.45M | +7 | −11 |
| Q4 2025 | 75 | 0 | 41.69M | $269.29M | +1 | −1 |
| Q3 2025 | 16 | 0 | 21.57M | $120.55M | +1 | −1 |
| Q2 2025 | 13 | +1 | 18.15M | $60.07M | +1 | — |
| Q1 2025 | 9 | -2 | 4.86M | $14.09M | — | −2 |
| Q4 2024 | 11 | +1 | 4.40M | $15.68M | +1 | — |
| Q3 2024 | 9 | +1 | 3.11M | $15.51M | +2 | −1 |
| Q2 2024 | 8 | — | 2.58M | $6.65M | — | — |
Who holds it · Q3 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 6.53M | +0.8% | $36.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passive) | 5.66M | +30.8% | $31.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passive) | 5.66M | +30.8% | $31.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passive) | 5.66M | +30.8% | $31.65M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 2.09M | +5.6% | $11.67M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 2.09M | +5.6% | $11.67M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (passive) | 1.60M | +6.3% | $8.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 1.41M | — | $7.88M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 1.41M | — | $7.88M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 1.41M | — | $7.88M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 1.41M | — | $7.88M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 1.41M | — | $7.88M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 1.41M | — | $7.88M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 1.41M | — | $7.88M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Millennium Management ✦ | 1.29M | -56.7% | $7.21M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 947.16K | — | $5.29M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 768.45K | +405.0% | $4.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 768.45K | +405.0% | $4.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | Goldman Sachs Group ✦ | 395.15K | — | $2.21M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Goldman Sachs Group ✦ | 395.15K | — | $2.21M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Marshall Wace ✦ | 371.07K | +411.3% | $2.07M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | Wellington Management ✦ | 285.78K | +16.5% | $1.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 285.78K | +16.5% | $1.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 285.78K | +16.5% | $1.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Renaissance Technologies ✦ | 87.00K | New | $486,330 | 0.0% | New | 1 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 57.77K | -1.7% | $322,962 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 57.77K | -1.7% | $322,962 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 57.77K | -1.7% | $322,962 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | T. Rowe Price ✦ | 45.09K | +5.0% | $253,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 25.50K | -60.6% | $142,545 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 4.85K | +108.3% | $27,134 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 4.85K | +108.3% | $27,134 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $486,330 | 0.0% |
Exited
| Two Sigma Investments | $794,115 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 174 holders, 66.03M shares, $284.02M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Aug 17
Barber Daniel
Officer, Director · 25.00K sh · $107,168
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
Jul 27
SC 13G/A — BlackRock, Inc.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2025 ·
Methodology ·
Get this via the API